Udenafil
- Generic Name
- Udenafil
- Drug Type
- Small Molecule
- Chemical Formula
- C25H36N6O4S
- CAS Number
- 268203-93-6
- Unique Ingredient Identifier
- L5IB4XLY36
Overview
Udenafil is a new phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED). It has been approved in South Korea and will be marketed under the brand name Zydena. It is not yet approved for use in the U.S., E.U., or Canada.
Background
Udenafil is a new phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED). It has been approved in South Korea and will be marketed under the brand name Zydena. It is not yet approved for use in the U.S., E.U., or Canada.
Indication
Investigated for use/treatment in erectile dysfunction and hypertension.
Associated Conditions
- Erectile Dysfunction
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath